Drug Shortage Report for DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP
| Report ID | 111045 |
| Drug Identification Number | 00761850 |
| Brand name | DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP |
| Common or Proper name | Dopamine |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | DOPAMINE HYDROCHLORIDE DEXTROSE |
| Strength(s) | .8MG 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 250mL |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2020-04-06 |
| Actual start date | 2020-04-06 |
| Estimated end date | 2020-05-01 |
| Actual end date | 2020-05-01 |
| Shortage status | Resolved |
| Updated date | 2020-05-02 |
| Company comments | Baxter products Dopamine Hydrochloride and 5% Dextrose USP – 400mg/250mL bags (DIN 00761826) and 800mg/250mL bags (DIN 00761834) are available as alternatives if they align with clinical practice. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-05-02 | English | Compare |
| v5 | 2020-05-01 | French | Compare |
| v4 | 2020-05-01 | English | Compare |
| v3 | 2020-04-07 | English | Compare |
| v2 | 2020-04-06 | French | Compare |
| v1 | 2020-04-06 | English | Compare |
Showing 1 to 6 of 6